By integrating AI/ML tools, SGA's healthcare market research and consulting services provide precision, comprehensive coverage, ROI, and a faster turnaround time for white-label research.
One of the few healthcare market research companies, SG Analytics (SGA) has been supporting pharmaceutical, medical devices, and life sciences companies to boost their revenue and increase their market shares in the last 10 years. Unlike many other healthcare market research firms, the team of experts at SGA ensures that the business data is safe. Our growth has been in the healthcare data management space, followed by market access, market entry, and competitive intelligence (CI). We are ranked among the best healthcare market research companies. In recent years, we have expanded our services across new segments like robotic data automation, ESG-pharma, and health economics and outcomes research (HEOR) to present the best healthcare market research services to our industry partners across the globe.
Using AI and ML tools, SGA has positioned itself as the global healthcare market research service provider. We offer the most relevant data metrics and insights into the niche segments of the healthcare industry. We are flexible in data management, using the Amazon Web Services (AWS) platform, or working on the client's server using a VPN.
Our healthcare market research team helps our global clients co-creating strategic roadmaps, communicate their plans to the right audience, and offer customized solutions for new product market entry strategies.
SG Analytics helps you generate evidence of the value of a new drug or product for reimbursement and healthcare payers using Artificial Intelligence (AI)/ Machine Language (ML) tools for crisp and precise solutions.
Over $500 billion worth of M&A deals are waiting to happen in the Global Healthcare market. We can help you tap into the right audience, technology due diligence, and healthcare intel and cut down the lag phase from search to ‘go to market.'
An amalgamation of strategies, marketing, and competitive intelligence (CI) for pharma, devices and diagnostic companies that are planning to introduce or check the adequate supply of products amid the market competition and price war.
We help you evaluate new entrant threats, track the current players and technology, check the pulse and power of the suppliers and buyers, and the availability of substitutes and counterfeits.
Identification, mapping, and engagement of Key Opinion Leaders (KOL) in healthcare through our in-house panel makes us, SG Analytics, the most preferred partner.
Why SGA
Industry Leaders
SGA thrives by its brand promise Lifes Possible, and is recognized as the trusted healthcare market research company in the USA.
12+ Languages
Language capabilities include Mandarin, Cantonese, Korean, German, Spanish, Arabic, Bahasa, Hindi, Bengali, and English experts (U.S./U.K.).
Data-Driven Insights
With in-depth domain knowledge and proven capabilities of delivering monetizable insights, we deliver high-quality, efficient outputs.
End-To-End Solutioning
The in-house KOL capability of more than 700, along with analytical and ML/AI capabilities, helps in presenting credible competitive information.
White Papers
Market Entry in 2023: Why Must You Also Look at Markets Other Than the US and Japan?
Due to dollar fluctuations and the likelihood of market recession, investors and manufacturers of medical devices and pharma are exploring new opportunities...
White Papers
The Blue Ocean Strategy in the Pharmaceutical Industry: What Is the Blue Ocean Strategy About?
Blue ocean refers to a new market that presents low competition, is less crowded, and is open to accommodate new innovations and marketing opportunities....
White Papers
What Happens When You Invest in Healthcare Consulting and Analytics?
Healthcare providers who are struggling with high-volume complex data are feeling the need for assistance with data convergence and management. With...
We strongly believe in women power. Our research team consists of more females than males i.e., 55 % females, and consists of PhDs, M Pharms, D Pharms, Postgraduate in finance, Biotech postgraduates, and MBAs.
